Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition treating ringworm of the nails, extremity tinea and method of manufacturing the same

A composition and technology for tinea pedis, applied in the directions of drug combinations, active ingredients of hydroxyl compounds, medical raw materials of non-living substances, etc., can solve problems such as insufficient curative effect, easy recurrence, damage to social image, etc., and achieve extremely strong sterilization and recurrence prevention effect. , The effect of promoting new nail growth and strong penetration

Inactive Publication Date: 2008-01-23
郭华岩
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] ②Affects the beauty of hands and damages social image
[0017] ③ Inconvenient life, such as shaking hands, serving tea, folding clothes, wearing socks, etc.
[0034] There are also many kinds of tinea pedis medicines for the existing treatment, both for external application and for internal use, but all of them have defects such as insufficient curative effect and easy recurrence to varying degrees.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Embodiment 1 The preparation of medicine of the present invention

[0055] Preparation of medicinal ointment: take each component according to the following parts by weight: 50 g of vaseline, 30 g of urea and 25 g of resorcinol; mix the above-mentioned components uniformly and stir thoroughly to obtain medicinal ointment;

[0056] Preparation of medicinal liquid: take each component according to the following parts by weight: 80 g of distilled water and 20 g of glacial acetic acid; fully mix the distilled water and glacial acetic acid to obtain the medicinal liquid.

Embodiment 2

[0057] Embodiment 2 The preparation of medicine of the present invention

[0058] Preparation of medicinal ointment: take each component according to the following parts by weight: 70g of vaseline, 50g of urea and 30g of resorcinol; mix the above-mentioned components uniformly and stir fully to obtain medicinal ointment;

[0059] Preparation of medicinal liquid: take each component according to the following parts by weight: 120 g of distilled water and 40 g of glacial acetic acid; fully mix the distilled water and glacial acetic acid to obtain the medicinal liquid.

Embodiment 3

[0060] Embodiment 3 The preparation of medicine of the present invention

[0061] Preparation of medicinal ointment: take each component according to the following parts by weight: vaseline 55g, urea 40g and resorcinol 30g; above-mentioned each component is mixed evenly, fully stirs, obtains medicinal ointment;

[0062] Preparation of medicinal liquid: take each component according to the following parts by weight: 100 g of distilled water and 30 g of glacial acetic acid; fully mix the distilled water and glacial acetic acid to obtain the medicinal liquid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine combination for curing onychomycosis and tinea manuum and pedis, which comprises an ointment and a liquid medicine that are prepared and applied independently. Wherein, the ointment comprises the following components with relevant weight shares: Vaseline of 50-70 shares, urea of 30-50 shares and resorcinol of 25-30 shares; the liquid medicine comprises the following components with relevant weight shares: distilled water of 80 to 120 shares and glacial acetic acid of 20 to 40 shares. The ointment in the invention has outstanding effects of eliminating true fungus and softening the affected nail; the liquid medicine has the effects of sterilizing and preventing the relapse, ensuring strong penetration and realizing double effects for curing and promoting the growth of new nail. With the coordination of the two medicines, the fungus can be eliminated and the affected disease source area can be completely sterilized, thus thoroughly curing the onychomycosis, realizing outstanding treatment effect for tinea manuum and pedis. Besides, in clinical medication, the invention results in no adverse reaction and ensures reliable treatment effect.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating onychomycosis and tinea manuum and a preparation method thereof, belonging to the field of medicine. Background technique [0002] Onychomycosis is a common name for an infectious disease that occurs on human nails. Medically, it was called onychomycosis before, and it is now called onychomycosis. It is caused by a large class of microbial infections called pathogenic fungi. Generally start to fall ill with 1-2 finger (toe) nails, and all finger (toe) nails of severe cases can suffer from. The diseased deck loses its luster, and the deck thickens and deforms over time, showing grayish white and dirty yellow. The deck becomes brittle and breaks off, and sometimes the deck separates from the nail bed. Onychomycosis, also known as onychomycosis, is caused by the most stubborn and intractable tinea pedis and tinea pedis in pathogenic disease...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/06A61K33/02A61K35/02A61K31/05A61P17/00A61K35/06
Inventor 郭华岩
Owner 郭华岩
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products